tetano
Editor, Senior Moderator
Hum Vaccin Immunother. 2015 Jun 19:0. [Epub ahead of print]
[h=1]Protection of young children from influenza through universal vaccination.[/h] Principi N[SUP]1[/SUP], Senatore L, Esposito S.
[h=3]Author information[/h]
[h=3]Abstract[/h] Influenza is a very common disease among infants and young children, with a considerable clinical and socioeconomic impact. A significant number of health authorities presently recommend universal influenza vaccination for the paediatric population, but a large number of European health authorities is still reluctant to include influenza vaccination in their national vaccination programs. The reasons for this reluctance include the fact that the protection offered by the currently available vaccines is considered poor. This review shows that although future research could lead to an increase in the immunogenicity and potential efficacy of influenza vaccines, the available vaccines, even with their limits, assure sufficient protection in most subjects aged ≥6 months, thus reducing the total burden of influenza in young children and justifying the recommendation for the universal vaccination of the whole paediatric population. For younger subjects, the vaccination of their mother during pregnancy represents an efficacious strategy.
[h=4]KEYWORDS:[/h] Adjuvants; children; influenza; influenza prevention; influenza vaccine; live attenuated influenza vaccine; pregnancy; quadrivalent influenza vaccine; trivalent influenza vaccine
PMID: 26090704 [PubMed - as supplied by publisher]
[h=1]Protection of young children from influenza through universal vaccination.[/h] Principi N[SUP]1[/SUP], Senatore L, Esposito S.
[h=3]Author information[/h]
[h=3]Abstract[/h] Influenza is a very common disease among infants and young children, with a considerable clinical and socioeconomic impact. A significant number of health authorities presently recommend universal influenza vaccination for the paediatric population, but a large number of European health authorities is still reluctant to include influenza vaccination in their national vaccination programs. The reasons for this reluctance include the fact that the protection offered by the currently available vaccines is considered poor. This review shows that although future research could lead to an increase in the immunogenicity and potential efficacy of influenza vaccines, the available vaccines, even with their limits, assure sufficient protection in most subjects aged ≥6 months, thus reducing the total burden of influenza in young children and justifying the recommendation for the universal vaccination of the whole paediatric population. For younger subjects, the vaccination of their mother during pregnancy represents an efficacious strategy.
[h=4]KEYWORDS:[/h] Adjuvants; children; influenza; influenza prevention; influenza vaccine; live attenuated influenza vaccine; pregnancy; quadrivalent influenza vaccine; trivalent influenza vaccine
PMID: 26090704 [PubMed - as supplied by publisher]